GGC-Food • GGC-Health • Longevity • Medicine
Kris Verburgh (1986) graduated magna cum laude as a medical doctor from the University of Antwerp, Belgium. Dr. Verburgh is a researcher at the Center Leo Apostel for Interdisciplinary Studies (CLEA) at the Free University Brussels (VUB) and a member of the Evolution, Complexity and Cognition group at the Free University of Brussels.
Dr. Verburgh’s fields of research are aging, nutrition, metabolism, preventive medicine and health. In this context, he created a new scientific discipline, called ‘nutrigerontology’, which studies the impact of nutrition on the aging process and aging-related diseases. Besides medicine, Dr. Verburgh has a keen interest in evolution, the origin and complexity of life, and neuroscience (consciousness, neurotheology, neuroesthetics, theory of mind and the origins of creativity).
At the age of 25, he was the author of 3 science books. His books got many reprints and nominations.
He wrote his first book at the age of 16, making him the youngest author of a science book in Europe. This book was nominated for the Eureka Science Prize.In his second book, that Verburgh wrote at the age of 21, he draws onrecent scientific discoveries and insights to answer age-old philosophical questions about the origin and evolution of life, human nature and consciousness. The book got 7 reprints and was also nominated for theEureka Science Prize.
In his third book The food hourglass Verburgh writes about a subject that is a strong interest of his: the aging process. In this book he uses latest scientific insights to explain how different kind of foods and food patterns can slow down or speed up the aging process. Because of his book Verburgh was nominated as one of the Most Important Persons of the Year.
Verburgh wrote articles for various newspapers and appeared in radio and television shows. He regularly gives lectures on medicine, health, aging and science.
How will the Fourth Industrial Revolution impact medicine and our health? How will treating and reversing the aging process transform medicine and society? What are currently the most promising new biotechnologies? New paradigm shifts in medicine will be discussed, how they will change our health, bodies and lifespans, and what this means for financial organizations and investors. Dr. Verburgh will also briefly address the risks, controversies, opportunities, and concerns of this Second Biotech Age and its consequences for society as a whole.